New Study Identifies Five Medication Prescribing Cascades that Risk Older Adults' Health

A new study identifies five medication prescribing cascades that may increase health risks for older adults, emphasizing the need for careful medication review in primary care to prevent adverse effects.
Recent research has highlighted the issue of 'prescribing cascades' among older adults, a phenomenon where one medication leads to the prescription of another to address side effects, potentially increasing health risks. An unintentional cascade can occur when symptoms caused by a medication are mistaken for new illnesses, prompting additional prescriptions that may expose patients to further adverse effects.
Researchers from University College Cork in Ireland analyzed prescription data for over half a million community-dwelling seniors aged 65 and above, spanning from 2017 to 2020. Their study, published in The Annals of Family Medicine, used a prescription sequence symmetry analysis within a year to identify nine potential prescribing cascades. The findings revealed that five of these cascades were significant:
- Calcium channel blockers associated with subsequent diuretic prescriptions,
- Alpha-1-receptor blockers linked to vestibular sedative prescriptions,
- SSRIs or SNRIs leading to sleep aid prescriptions,
- Benzodiazepines followed by antipsychotic medication,
- Antipsychotics subsequently resulting in anti-Parkinsonian drugs.
Additionally, three drug pairs showed negative associations, indicating a lower likelihood of sequence from the first to the second medication, including diuretics to overactive bladder medications, benzodiazepines to antidementia drugs, and NSAIDs to antihypertensive medications. Recognizing these patterns is crucial for primary care clinicians to evaluate potential adverse drug reactions when patients exhibit new symptoms. Incorporating awareness of prescribing cascades can help reduce medication-related harm among older adults.
This research underscores the importance of careful medication management and thorough assessment in primary care settings to prevent unnecessary treatments and protect vulnerable populations.
For more details, refer to the original publication: Ann Sinéad Doherty et al., "Prescribing Cascades Among Older Community-Dwelling Adults," The Annals of Family Medicine (2025).
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative AI Model Identifies Genes and Drug Combinations to Reverse Disease in Cells
Harvard Medical School introduces PDGrapher, an AI tool that identifies key genes and drug combinations to reverse disease states in cells, accelerating drug discovery and personalized treatment development.
New Long Noncoding RNA Identified as Potential Target for Prostate Cancer Therapy
A new study identifies a specific long noncoding RNA, PRCAT71, as a potential biomarker and therapeutic target for prostate cancer, revealing new pathways for treatment.
Advancing Clinical Practice with Pharmacogenomic-Guided Prescribing
Discover how pharmacogenomics is revolutionizing medication prescribing by integrating genetic data into routine healthcare practices, improving safety and efficacy.
New Guidelines for Long-Term Follow-Up Care of Young Adult Cancer Survivors
A new comprehensive review offers tailored long-term follow-up care recommendations for young adult cancer survivors, focusing on physical health, mental well-being, and early detection of secondary conditions.